SCHEMBL5770396

SCHEMBL5770396

CCCNC(=O)C1(C)COC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(N(C)C)n3)[nH]2)OC1

nearest known ligand 0.72

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 11/20 0.72
MAPK12 P53778 11/20 0.72
MAPK11 Q15759 11/20 0.72
MAPK14 Q16539 11/20 0.72
SOAT1 P35610 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27724119 0.93 MAPK13 (0.69) MAPK13MAPK12MAPK11MAPK14SOAT1
SCHEMBL28776516 0.92 MAPK13 (0.68) MAPK13MAPK12MAPK11MAPK14SOAT1
SCHEMBL5771397 0.90 MAPK13 (0.70) MAPK13MAPK12MAPK11MAPK14SOAT1
SCHEMBL5770567 0.90 MAPK13 (0.61) MAPK13MAPK12MAPK11MAPK14SOAT1
SCHEMBL5768775 0.90 MAPK13 (0.73) MAPK13MAPK12MAPK11MAPK14
SCHEMBL5772012 0.90 MAPK13 (0.62) MAPK13MAPK12MAPK11MAPK14SOAT1
SCHEMBL5767640 0.89 MAPK13 (0.69) MAPK13MAPK12MAPK11MAPK14SOAT1
SCHEMBL5771174 0.89 MAPK13 (0.86) MAPK13MAPK12MAPK11MAPK14
SCHEMBL5769311 0.89 MAPK13 (0.79) MAPK13MAPK12MAPK11MAPK14
SCHEMBL5768838 0.89 MAPK13 (0.64) MAPK13MAPK12MAPK11MAPK14SOAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100443481-C Imidazolyl-cyclic acetals RHONE POULENC RORER LTD (GB) 2008-12-17 CN disclosed
EP-0988301-B1 IMIDAZOLYL-CYCLIC ACETALS AVENTIS PHARMA LTD (GB) 2006-08-09 EP disclosed
US-6989395-B2 Imidazolyl-cyclic acetals AVENTIS PHARMA LIMITED (GB) 2006-01-24 US disclosed
US-20040038991-A1 Imidazolyl-cyclic acetals AVENTIS PHARMA LIMITED (GB) 2004-02-26 US disclosed
US-6602877-B1 Imidazolyl-cyclic acetals AVENTIS PHARMA LIMITED (GB) 2003-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040038991-A1 Imidazolyl-cyclic acetals CBR1, LBR, CBR3 MAPK13 1610/4885MAPK12 2766/4885MAPK11 1125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.